Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Pilot Phase II Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

NCT00276926 is registered in ClinicalTrials.gov with University of Bologna as lead sponsor.

NCT NCT00276926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00276926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Pilot Phase II Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias
Lead sponsor
University of Bologna
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2003
Completion date
Not reported
Enrollment
Not reported
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

chronic eosinophilic leukemia (cel), hypereosinophilic syndrome, myeloproliferative disorders